Clinical Research Directory
Browse clinical research sites, groups, and studies.
Growth Hormone Replacement Therapy for Retried Professional Football Players
Sponsor: Center for Neurological Studies
Summary
This is a randomized, double-blind, placebo-controlled, parallel-group trial with an open-label extension to evaluate the efficacy of growth hormone (GH) on cognitive functions of retired professional football players with growth hormone deficiency (GHD).
Official title: Interventional Study of Growth Hormone Replacement Therapy in Retired Professional Football Players With Growth Hormone Deficiency
Key Details
Gender
MALE
Age Range
18 Years - 76 Years
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2019-10-08
Completion Date
2026-09
Last Updated
2023-02-08
Healthy Volunteers
No
Conditions
Interventions
Growth Hormone
Daily self-injections by subjects: 1-year double-blind phase; 6-month open-label extension for those who received placebo during the double-blind phase
Placebo
Daily self-injections by subjects: 1-year double-blind phase
Locations (1)
Center for Neurolgoical Studies (CNS)
Dearborn, Michigan, United States